NanoViricides, Inc. discovers, develops, and commercializes drugs for the treatment of viral infections.Company develops Human Coronavirus Program for COVID-19 seasonal coronavirus affliction. Company also develops FluCide Broad-Spectrum Anti-Influenza nanoviricide.